Naming biotech drugs to be scrutinised
This article was originally published in Scrip
Executive Summary
The World Health Organization's INN secretariat is to look at definitions for glycoproteins, such as erythropoietins, and will set up an expert group to review the naming of monoclonal antibodies, says the summary of its 46th meeting, which was held in April.